title: Endocrine sequelae of childhood craniopharyngioma.
abstract: The endocrine sequelae of 62 children with craniopharyngioma were studied retrospectively. These patients were followed for a median duration of 3 years (range 1 to 10 years). Eighteen patients had a long-term follow-up for more than 5 years (range 5 to 10 years). Complete surgical resection was achieved in 30 patients and 32 patients had residual tumor. Twenty-five patients had recurrence or progression of the residual tumor and were treated with radiotherapy. Presenting complaints suggestive of endocrinopathy were infrequent. The most common presenting symptoms were headache, nausea and vomiting, followed by growth failure. Pre-operatively, growth hormone deficiency was the most commonly encountered pituitary hormonal deficiency; however postoperatively, most children had diabetes insipidus. Multiple pituitary hormonal deficiencies were more frequently observed in children treated with extensive radical surgery than in those treated with conservative surgery and radiotherapy. The endocrine morbidity associated with craniopharyngioma and its different management modalities remains high; however, it is manageable with appropriate hormonal replacement therapy.
authors.affiliation: Department of Pediatrics, King Faisal Specialist Hospital and Research Hospital, Riyadh, Saudi Arabia. binabbas@kfshrc.cdu.sa
authors.forename: B
authors.initials: B
authors.lastname: Bin-Abbas
authors.forename: H
authors.initials: H
authors.lastname: Mawlawi
authors.forename: N
authors.initials: N
authors.lastname: Sakati
authors.forename: Y
authors.initials: Y
authors.lastname: Khafaja
authors.forename: M A
authors.initials: MA
authors.lastname: Chaudhary
authors.forename: A
authors.initials: A
authors.lastname: Al-Ashwal
mesh_terms: D000293:Adolescent; D001827:Body Height; D002648:Child; D002675:Child, Preschool; D003131:Combined Modality Therapy; D003397:Craniopharyngioma / Q000097:blood / Q000000981:diagnostic imaging / Q000628:therapy*; D005260:Female; D005500:Follow-Up Studies; D020249:Hormone Replacement Therapy; D006728:Hormones / Q000097:blood*; D006801:Humans; D007223:Infant; D008279:Magnetic Resonance Imaging; D008297:Male; D010911:Pituitary Neoplasms / Q000097:blood / Q000000981:diagnostic imaging / Q000628:therapy*; D011184:Postoperative Period; D012189:Retrospective Studies; D014057:Tomography, X-Ray Computed
chemical_list: D006728:Hormones